Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03650569

NCT03650569
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Angelman syndrome through genetic/molecular testing.

Who may not be able to join:

  • You do not meet the accepted diagnostic criteria for Angelman syndrome.
  • You have other medical or genetic conditions, except that having autism alongside Angelman syndrome appears to be acceptable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Registry
clinicaltrials_gov
Start date
16 February 2018
Est. completion
16 February 2021

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Medical and behavioral problems

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov